Belgium

Galapagos NV is bolstering its ability to select drug targets and compounds by acquiring Inpharmatica Ltd in an all-share transaction that values the UK bioinformatics company at €12.5 million.

OncoMethylome Sciences is planning to raise funds via an IPO. Its diagnostics can detect early-stage cancer and predict the response to particular cancer drugs.